Fornecendo informações sobre diretrizes para artrite reumatoide no Brasil
Tipo de documento
Pôster
Descrição
Resumo apresentado na Health Technology Assessment international (HTAi)
Fonte
HTAi
Ano de publicação
2018
Referência (Vancouver)
Guerra A, Dias C, Borin M, dos Santos J, da Silva M, Diniz I, Ribeiro N Jr, Alvares J, Acurcio F. Providing Information About Rheumatoid Arthritis Guideline In Brazil. In: HTAi Annual Meeting Abstract Book; 2018 June 1-5; Vancouver, Canada. Health Technology Assessment International, HTAi; 2018. p. 287-288. PP76.
Identificador
2018HTAi031
Title
Providing information about rheumatoid arthritis guideline in Brazil
Description
Abstract presented at Health Technology Assessment international (HTAi)
Source
HTAi
Publication year
2018
Reference (Vancouver)
Guerra A, Dias C, Borin M, dos Santos J, da Silva M, Diniz I, Ribeiro N Jr, Alvares J, Acurcio F. Providing Information About Rheumatoid Arthritis Guideline In Brazil. In: HTAi Annual Meeting Abstract Book; 2018 June 1-5; Vancouver, Canada. Health Technology Assessment International, HTAi; 2018. p. 287-288. PP76.
Identifier
2018HTAi031
Resumo
Introdução: O Componente Especializado da Assistência Farmacêutica (CEAF) é uma estratégia para acesso a medicamentos de alto custo no Sistema Único de Saúde (SUS) do Brasil, visando garantir a integralidade do tratamento médico cujas linhas de cuidado estão definidas nos Protocolos Clínicos e Diretrizes Terapêuticas (PCDT). Para acessar o CEAF, o médico deve fornecer ao paciente um formulário preenchido, seguindo alguns requisitos e os PCDT. Com o intuito de melhorar a prescrição racional e facilitar o acesso dos pacientes aos medicamentos, realizamos visitas a médicos e apresentamos informações chave sobre os PCDT da Artrite Reumatoide (AR) e o processo de solicitação de medicamentos do CEAF, buscando conhecer suas percepções. Resultados: Os médicos, em sua maioria especialistas, já possuíam conhecimento sobre os PCDT e as práticas de prescrição dos medicamentos do CEAF; no entanto, demonstraram interesse nas visitas para revisar e aprimorar seus conhecimentos e práticas clínicas. Conclusões: Os médicos, que eram em sua maioria especialistas, já tinham conhecimento sobre os PCDT e as práticas de prescrição dos medicamentos do CEAF, mesmo assim, mostraram interesse nas visitas para revisar e aprimorar seu conhecimento e prática clínica.
Notas
O registro foi originalmente publicado em inglês. A versão em português foi traduzida com o apoio de inteligência artificial.
Abstract
Introduction: Specialized Component of Pharmaceutical Service (SCPS) is a strategy to access high cost medicines in the National Health System (NHS) of Brazil, to ensure integrality of medical treatment whose lines of care are defined in the Clinical Protocols and Therapeutic Guidelines (CPTG). To access the SCPS, the physician has to give to the patient a filled form, following some requirements and the CPTGs. In order to improve the rational prescription and facilitate patients’ access to medicines, we visited physicians and presented key information regarding the CPTGs of Rheumatoid Arthritis (RA) and the SCPS medicines request process, then, we sought to know their perception. Methods: Specialized Component of Pharmaceutical Service (SCPS) is a strategy to access high cost medicines in the National Health System (NHS) of Brazil, to ensure integrality of medical treatment whose lines of care are defined in the Clinical Protocols and Therapeutic Guidelines (CPTG). To access the SCPS, the physician has to give to the patient a filled form, following some requirements and the CPTGs. In order to improve the rational prescription and facilitate patients’ access to medicines, we visited physicians and presented key information regarding the CPTGs of Rheumatoid Arthritis (RA) and the SCPS medicines request process, then, we sought to know their perception. Results: Specialized Component of Pharmaceutical Service (SCPS) is a strategy to access high cost medicines in the National Health System (NHS) of Brazil, to ensure integrality of medical treatment whose lines of care are defined in the Clinical Protocols and Therapeutic Guidelines (CPTG). To access the SCPS, the physician has to give to the patient a filled form, following some requirements and the CPTGs. In order to improve the rational prescription and facilitate patients’ access to medicines, we visited physicians and presented key information regarding the CPTGs of Rheumatoid Arthritis (RA) and the SCPS medicines request process, then, we sought to know their perception. Conclusions: The physicians, who were mostly specialists, already had knowledge about CPTG and prescription practices of SCPS’s medicines even though, they showed interest in the visits to review and improve their knowledge and clinical practice.
Notes
The record was originally published in English. The Portuguese version was translated with the support of artificial intelligence.
